Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,656 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,001 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $595.21 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $447.96 | 4 | $0 (2024) |
| BioXcel Therapeutics, Inc. | $243.39 | 3 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $129.30 | 1 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125.55 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $113.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,058 | 7 | Janssen Pharmaceuticals, Inc ($595.21) |
| 2023 | $626.40 | 7 | Alkermes, Inc. ($296.32) |
| 2022 | $495.81 | 5 | Alkermes, Inc. ($252.52) |
| 2021 | $476.17 | 4 | Teva Pharmaceuticals USA, Inc. ($238.15) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $97.78 | General |
| Category: CNS | ||||||
| 08/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Neuroscience | ||||||
| 08/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.55 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: Neurology | ||||||
| 05/29/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $116.01 | General |
| Category: CNS | ||||||
| 04/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.01 | General |
| Category: Neuroscience | ||||||
| 02/29/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $448.01 | General |
| Category: Neuroscience | ||||||
| 09/13/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $68.39 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $57.24 | General |
| Category: CNS | ||||||
| 07/19/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $119.61 | General |
| Category: CNS | ||||||
| 07/13/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $86.69 | General |
| Category: Neurology | ||||||
| 01/24/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $119.47 | General |
| Category: CNS | ||||||
| 12/02/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $129.30 | General |
| Category: INSOMNIA | ||||||
| 07/27/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $104.28 | General |
| Category: CNS | ||||||
| 05/18/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $52.80 | General |
| Category: CNS | ||||||
| 03/23/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $95.44 | General |
| Category: CNS | ||||||
| 03/03/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $113.99 | General |
| Category: Neuropsychiatry | ||||||
| 11/09/2021 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $114.56 | General |
| Category: CNS | ||||||
| 08/05/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $123.34 | General |
| Category: Central Nervous System | ||||||
| 06/22/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $114.81 | General |
| Category: Central Nervous System | ||||||
| 06/10/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $123.46 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 20 | 47 | $29,898 | $2,536 |
| 2021 | 1 | 29 | 68 | $36,645 | $5,620 |
| 2020 | 2 | 80 | 127 | $45,203 | $6,721 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 47 | $29,898 | $2,536 | 8.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 68 | $36,645 | $5,620 | 15.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 84 | $34,621 | $5,304 | 15.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 43 | $10,582 | $1,417 | 13.4% |
About Nataliya Hayes
Nataliya Hayes is a Registered Nurse healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1316355266.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nataliya Hayes has received a total of $2,656 in payments from pharmaceutical and medical device companies, with $1,058 received in 2024. These payments were reported across 23 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($2,656).
As a Medicare-enrolled provider, Hayes has provided services to 129 Medicare beneficiaries, totaling 242 services with total Medicare billing of $14,877. Data is available for 3 years (2020–2022), covering 4 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health, Psychiatric/Mental Health
- Location Denver, CO
- Active Since 07/23/2014
- Last Updated 02/26/2020
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1316355266
Products in Payments
- LYBALVI (Drug) $498.42
- INVEGA SUSTENNA (Drug) $448.01
- ARISTADA (Drug) $278.48
- IGALMI (Drug) $243.39
- AUSTEDO (Drug) $238.15
- UZEDY (Drug) $209.81
- SPRAVATO (Drug) $147.20
- QUVIVIQ (Drug) $129.30
- CAPLYTA (Drug) $125.55
- Vivitrol (Drug) $119.47
- INGREZZA (Drug) $113.99
- VIVITROL (Drug) $104.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Denver
Jose Diaz Leo, Np-C, NP-C
Registered Nurse — Payments: $20,349
Noreedn Nicol, Np, NP
Registered Nurse — Payments: $16,991
Gina Fidler, Np, NP
Registered Nurse — Payments: $5,867
Dr. Jamie Mccartney Herbert, Pmhnp-Bc, PMHNP-BC
Registered Nurse — Payments: $2,707
Peter Prutch, Np, NP
Registered Nurse — Payments: $2,646
Emily Mccollum, Pmhnp, PMHNP
Registered Nurse — Payments: $2,511